PARLIAMENTARY WRITTEN QUESTION
Thyroid Gland: Diseases (3 February 2016)
Question Asked
To ask the Secretary of State for Health, what steps he plans to take in response to increases in the cost to the NHS of Liothyronine; and if he will make a statement.
Asked by:
Gareth Thomas (Labour)
Asked by:
Gareth Thomas (Labour)
Answer
The Government’s policy on generic medicines is to allow manufacturers freedom of pricing for their products, relying on competition to deliver value for money. Any potential pricing abuses are a matter for the Competition and Markets Authority (CMA). The Department is in regular contact with the CMA.
Answered by:
George Freeman (Conservative)
8 February 2016
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.